Cargando…
COVID-19 in Patients with Chronic Lung Disease
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus that causes an acute respiratory tract infection known as coronavirus disease 2019 (COVID-19). SARS-CoV-2 enters cells by binding the ACE2 receptor and coreceptors notably TMPRSS2 or Cathepsin L. Severe COVID-19 infe...
Autores principales: | Calver, Jessica Fae, Fabbri, Laura, May, James, Jenkins, R. Gisli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678841/ https://www.ncbi.nlm.nih.gov/pubmed/37085227 http://dx.doi.org/10.1016/j.ccm.2022.11.013 |
Ejemplares similares
-
COVID‐19 and pulmonary fibrosis: A potential role for lung epithelial cells and fibroblasts
por: John, Alison E., et al.
Publicado: (2021) -
Beyond epithelial damage: vascular and endothelial contributions to idiopathic pulmonary fibrosis
por: May, James, et al.
Publicado: (2023) -
Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy
por: George, Peter M, et al.
Publicado: (2020) -
Reply to Althuwaybi et al.: Hospitalization Outcomes for COVID-19 in Patients with Interstitial Lung Disease: A Potential Role for Aerodigestive Pathophysiology?
por: Chaudhuri, Nazia, et al.
Publicado: (2021) -
Three Steps to Cure Pulmonary Fibrosis. Step 1: The Runaway Train or
Groundhog Day?
por: Jenkins, R. Gisli
Publicado: (2020)